Next Article in Journal
Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
Next Article in Special Issue
The Supercapsular Percutaneously Assisted Total Hip (SuperPATH) Approach Revisited: Technique Improvements after the Perioperative Experience of 344 Cases
Previous Article in Journal
Design of an Articulated Neck to Assess Impact Head-Neck Injuries
Previous Article in Special Issue
Does Surgical Repair Benefit Pipkin Type I Femoral Head Fractures?: A Systematic Review and Meta-Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Life
Volume 12
Issue 2
10.3390/life12020314
life-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Postoperative Delirium and Postoperative Cognitive Dysfunction in Patients with Elective Hip or Knee Arthroplasty: A Narrative Review of the Literature

by
Petros Kitsis
1,2,*,
Theopisti Zisimou
1,3,
Ioannis Gkiatas
1,
Ioannis Kostas-Agnantis
1,
Ioannis Gelalis
1,
Anastasios Korompilias
1 and
Emilios Pakos
1
1
Department of Orthopaedic Surgery, School of Medicine, University of Ioannina, Stavrou Niarchou Street, 45500 Ioannina, Greece
2
Orthopaedic Department, Nicosia General Hospital, Lemesou 215, Strovolos, 2029 Nicosia, Cyprus
3
Hippocrateon Hospital, 6-12 Psaron Street, Engomi, 2408 Nicosia, Cyprus
*
Author to whom correspondence should be addressed.
Life 2022, 12(2), 314; https://doi.org/10.3390/life12020314
Submission received: 10 January 2022 / Revised: 6 February 2022 / Accepted: 18 February 2022 / Published: 20 February 2022
(This article belongs to the Special Issue Orthopaedic Trauma and Reconstruction)
Browse Figures
Versions Notes

Abstract

:
Postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) are common complications following total knee arthroplasty (TKA) and total hip arthroplasty (THA), affecting the length of hospital stay and increasing medical complications. Although many papers have been published on both conditions in this setting, no reviews have currently been written. Thus, the purpose of our study is to summarize the current literature and provide information about POD and POCD following elective THA or TKA. Our literature search was conducted in the electronic databases PubMed and the Cochrane library. We found that POD is a common complication following elective THA or TKA, with a median incidence of 14.8%. Major risk factors include older age, cognitive impairment, dementia, preoperative (pre-op) comorbidities, substance abuse, and surgery for fracture. Diagnosis can be achieved using tools such as the confusion assessment method (CAM), which is sensitive, specific, reliable, and easy to use, for the identification of POD. Treatment consists of risk stratification and the implementation of a multiple component prevention protocol. POCD has a median incidence of 19.3% at 1 week, and 10% at 3 months. Risk factors include older age, high BMI, and cognitive impairment. Treatment consists of reversing risk factors and implementing protocols in order to preserve physiological stability. POD and POCD are common and preventable complications following TKA and THA. Risk stratification and specific interventions can lower the incidence of both syndromes. Every physician involved in the care of such patients should be informed on every aspect of these conditions in order to provide the best care for their patients.

1. Introduction

Total hip and total knee replacements are among the most commonly performed surgical procedures at present. These procedures are two of the most cost-effective and consistently successful surgeries performed in orthopedics. The most common indication for both surgeries is osteoarthritis. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) provide reliable outcomes, such us pain relief, functional restoration, and overall improved quality of life. Although the benefits outweigh the drawbacks, these procedures do not come without complications. Delirium and postoperative cognitive dysfunction are such, with their numbers increasing due to the increasing number of THAs and TKAs performed. Every physician involved in the care of postoperative (post-op) THA and TKA patients should be informed on every aspect of these conditions in order to provide the best care for their patients [1,2,3,4,5,6].
Delirium is a neuropsychological syndrome characterized by a disturbance in attention and awareness, which is an acute change from baseline, disturbance in cognition and fluctuating in severity during the course of the day. Postoperative delirium (POD) is a specific subset of delirium that is not related to emergence from anesthesia. Postoperative cognitive dysfunction (POCD) is associated with increased mortality, risk of leaving the labor market prematurely, and a dependency on social transfer payments. It is a syndrome characterized by the impairment of cognitive function that is distinct from delirium and dementia. Features of POCD include limitations in memory, intellectual ability, and executive function. Both syndromes are common complications following surgery, and are associated with prolonged hospital stay [7,8,9,10], medical complications [7,11,12,13], and delayed mobilization [10].
Nonetheless, there is a deficiency of written reviews of the literature regarding POCD and POD following elective TKA or THA. Therefore, the main goal of this review is to summarize the literature and provide the reader with the necessary information regarding these entities. More specifically, it will provide information on the epidemiology, incidence, risk factors, diagnosis, and treatment of both syndromes in patients undergoing these procedures, in order to make the reader more familiar with these entities and to enhance the knowledge in the clinical practice, as these syndromes are in most cases preventable.

2. Materials and Methods

We searched the electronic databases PubMed (in mesh terms) and the Cochrane library, using the following terms: “mental disorder”, “neurobehavioral manifestations”, “elective hip arthroplasty”, and “elective knee arthroplasty”. We set no date of publication limitation. Our search resulted in over 560 articles, from which less than one hundred fit the inclusion criteria. After that, we performed a manual search of the references in the selected articles. We consequently obtained over 95 articles that were included in our study. The inclusion criteria for our review were: articles in the English language, articles related to elective hip replacement or elective knee arthroplasty, articles related to POD or POCD, and, more specifically, articles that referred to POD or POCD as postoperative complications. Case reports were excluded. Studies were qualitative assessed using the methodological index for non-randomized studies (MINORS), as explained in Scheme 1 [14]. Following that, we divided studies according to their score into four levels, A, B, C, and D. Where contradicting evidence were present we used the following criteria in order to draw a conclusion favoring the one view vs. the other: criterion I was fulfilled if two or more studies were graded as one level higher than those of the opposing view, criterion II was fulfilled if one or more studies were graded as two levels higher, and criterion III (sample criterion) was fulfilled if the collective sample was −15% of opposing studies, or more. To draw a conclusion favoring one view, we required either criterion I plus criterion III, or criterion II plus criterion III, otherwise we were unable to make a concluding statement (Scheme 1).

3. Results and Discussion

3.1. POD

Delirium is defined by the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-5) as a neuropsychological syndrome characterized by disturbance in attention and awareness (which is an acute change from baseline, fluctuating in severity during the course of the day), and an additional disturbance in cognition, not explained by a pre-existing or evolving neurocognitive disorder or a reduced level of arousal. Lastly, there should be evidence of an attributable cause. POD is a specific subset of delirium, and is not related to emergence from anesthesia [15]. It usually occurs within the first 72 h post-op [16,17,18,19,20,21], with most cases occurring between 24–48 h [16,17,18,20,21]. On average, POD lasts for 1.8 days [22].

3.1.1. Epidemiology

There was a considerable variation among the incidences reported by individual studies (0–48%), with a median of 14.8%. Most of the studies fell between 10–15% (Table 1) [9,11,12,13,16,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46].
There are numerous factors responsible for the great variation in the literature. Firstly, the post-op day in which researchers evaluated the presence of POD differed between the studies. In a meta-analysis, JE Scott et al. reported that the incidence was higher among the studies that evaluated the presence of POD in the first 48 h post-op than studies that conducted the evaluation >72 h post-op [21]. Furthermore, different researchers used different tools/criteria to diagnose POD; each diagnostic tool possesses different levels of sensitivity and specificity, and this is reflected in the incidence range reported above. In some studies, the evaluation took place by psychiatrists, whereas in other studies evaluation was carried out by an orthopedic surgeon, or by the ward nurses in some cases. Additionally, the difference in the inclusion and exclusion criteria between the studies is a major confounding factor. Considering the above, the need for homogenous research regarding the incidence of POD is clear.

3.1.2. Risk Factors

Identifying the risk factors for POD after elective THA/TKA is of the utmost importance since the basis for treatment is determined by risk stratification protocols; thus, an accurate presentation of the risk factors helps the reader to understand the treatment approach, which will be discussed later, and also sets the basis for future risk stratification protocols regarding this specific subset of patients (Table 2).
Older age (>70 years old) is clearly correlated with increased risk of POD [9,10,11,12,17,18,31,47,48,49,50,51]. Some reports show that for every year of age the risk of POD increases by a factor of 1.1–1.15 [18,47]. Studies addressing the relationship between sex and POD show contradictory results, with some suggesting that males have a higher risk of developing POD [7,12,50,52], and others that implying there is no association [8,10,11,18]. Thus, we cannot make a key statement regarding sex and POD. There is also a lack of agreement in the literature regarding the race factor, with some stating that the white race has a higher risk of POD than other races [7], whereas others found no correlation [16].
Preoperative cognitive decline increases the risk of POD [4,11,25,31,32,37,43,50]; however, the existing literature failed to clearly correlate a cognitive function screening test, i.e., mini-mental state examination (MMSE), and the risk of POD, with few studies showing a positive interconnection between ΜΜSE and POD [11,16,20,37], while others show no statistically significant interrelationship [31,32,43,50]. In summary, more research is needed to determine which cognitive function screening tool correlates with the POD risk. Regarding dementia, the literature shows a statistically significant correlation with POD, with one study reporting an OR (odds ratio) of 10.4 [10,18]. It is worth noting that there are only a few studies addressing this relationship, because the majority of authors exclude demented patients from their studies.
Preoperative (pre-op) comorbidities, such as electrolytic imbalances, abnormal weight loss, cardiac disease (congestive heart failure, arrhythmias, coronary disease), coagulopathy, diabetes, asthma, chronic obstructive pulmonary disease (COPD), stroke, smoking, renal disease, and ASA grade 3 or higher (American Society of Anesthesiologist physical status grade) correlates with POD [7,9,10,17,47,50,51]. However, a number of questions regarding pre-op comorbidity remain to be addressed. In each individual study, the authors examined a specific subset of comorbidities, leaving others out. Furthermore, some authors addressed comorbidities via a score, such as ASA or the Charlson comorbidity index (CCI). Considering the above, we are unable to conclude how specific diseases correlate with POD, although we can state with certainty that patients with comorbidities are more likely to develop POD than patients without.
Obstructive sleep apnea (OSA) seems to correlate with POD [16,53]. R M Gupta et al. stated that OSA is not correlated with POD; however, there are some important limitations to their study. More specifically, since theirs was a case–control study, it is susceptible to bias, and there was no clear statement of the method used for the diagnosis of POD (this was noted by caregivers) [54].
The type of surgery (TKA or THA) and POD seems to be correlated, with some studies showing a stronger relationship between TKA and POD than THA [17,31,47]. Moreover, a meta-analysis by J E Scott et al. showed the same result regarding the type of surgery and POD, although without statistical significance [21]. Additionally, if we compare the fracture vs. elective surgeries, the first pose a greater risk of the development of POD than the latter [21]. Other than the type of surgery itself, increased blood loss during surgery correlates with POD [10,31], although the number of blood transfusions does not correlate with POD [10]. It is worth mentioning that in non-elective settings, operation duration of >3 h significantly increases the risk of POD by six times compared to a duration of <3 h [55]. Researching the literature for elective THA/TKA, no studies were found that addressed this matter with statistically significant results.

3.1.3. History of Neuropsychiatric Conditions

Regarding depression and POD, there is contradicting evidence in the literature. Although some authors referred to the correlation as an axiom, reviewing previous papers showed that some studies indicate an increased risk of POD in patients with depression [7,11,52], while others found no connection [20,37,47,56]. Schizophrenia seems to correlate with POD; for example, J Joseph Gholson et al. reported a positive interconnection between these factors, with an OR of 11.2 [57]. Parkinson’s disease (PD) increases the incidence of POD. For instance, Jared M Newman et al. reported an OR of 2.61 in patients with PD vs. control group [58,59]. Even though numerous papers have addressed the relationship between alcohol abuse and POD, we are still not able to make a clear statement due to the contradicting results. Some authors, such as Keith T Aziz et al., suggest a strong relationship between alcohol abuse and POD [7,38], while others report no relationship [11,37,47,52]. In addition, we can assume that studies that addressed pre-op comorbidities with ASA scores included patients with alcohol dependence or abuse, so it is difficult to make a key statement. Since alcohol dependence or abuse is a common problem in patients, the need for more research examining the relationship with POD is mandatory. Other substance abuse is clearly associated with an increased risk of POD development [7,32]. Furthermore, as stated by Akira Kudoh et al. chronic benzodiazepine users are at a higher risk of developing POD.
Summarizing, we can say with certainty that older age (>70 years old), preoperative cognitive impairment, dementia, pre-op comorbidities, schizophrenia, PD, substance abuse, chronic benzodiazepines usage, OSA, TKA, fracture, and increased blood loss during surgery are risk factors for developing POD.

3.1.4. Diagnosis

There are many diagnostic tools and methods used in clinical practice to diagnose delirium. The most popular is the confusion assessment method (CAM), followed by DSM criteria IV [60]. Other tools less frequently used are the DSM ΙΙΙ-revised, DSM V, delirium symptom interview (DSI), and the delirium rating scale-revised-98 (DRS-R-98).
The CAM instrument, which can be completed in less than 5 min, consists of the following four criteria: acute onset and fluctuating course, inattention, disorganized thinking, and altered level of consciousness. The CAM algorithm for the diagnosis of delirium requires the presence of both the first and the second criteria, and either the third or the fourth criterion. It has high sensitivity and specificity, and is also simple to use [61]. The diagnosis via DSM criteria requires a more thorough evaluation in most cases by a psychiatrist, thus is harder to use in daily clinical practice.
Considering the above, CAM is an easy-to-use tool for the diagnosis of POD and should be used in clinics providing care for elective TKA/THA patients. Using the other methods is more time consuming, and some require specialist training, making their everyday use impracticable.

3.1.5. Pathophysiology and Biomarkers

There have been efforts to identify biomarkers in blood/CSF, or even ultrasound findings, to predict the proportion of the population at risk of POD. Given the consistent association between cognitive impairment and POD, biomarkers of Alzheimer’s disease (AD) have been investigated as predictors. The apolipoprotein (APOE) e4 allele, the main genetic risk factor for AD; cerebrospinal fluid (CSF); amyloid b 42 (Ab42); total tau (T-tau); and phospho-tau (P-tau) have been studied. Reviewing the literature showed that the level of APOE e4 allele does not correlate with POD [25,47], although there is a correlation between low CSF ab42 and POD [47]. Zhongcong Xie et al. examined whether the lower preoperative CSF–Aβ/Tau ratio was associated with higher incidence of POD. They divided the participants into quartiles according to the levels of the preoperative CSF–Aβ/Tau ratio, and compared the incidence of POD among these quartiles. Their results showed that more POD incidences occurred in the lowest quartile of CSF–Aβ/Tau ratio than in the rest of three quartiles [44]. Although their seems to be a relationship between the AD biomarkers and POD, more research is needed to determine the specifics of this relationship, and make the use of biomarkers in the clinical practice possible.
Τhe pathophysiology of POD is not fully understood. One theory suggests that proinflammatory cytokines secreted in the periphery due to surgical trauma interact with the neural tissue, causing neuroinflammation, which leads to the syndrome’s manifestation. This interaction can occur either directly via vagal afferents, or indirectly through transportation through the blood–brain barrier or the periventricular areas, where the blood–brain barrier is incomplete or absent. The cytokine signal transmission stimulates the microglia to produce inflammatory cytokines, which results in neuroinflammation. Through this mechanism, surgical trauma may cause POD; thus, modulators of inflammation might play a key role in the development of this condition [62,63]. In this context, the cholinergic anti-inflammatory pathway, in which acetylcholine (ach) acts as a modulator of the immune response and inhibits proinflammatory cytokine production in a dose-depended manner, might have a key role in the pathophysiology of POD. This led researchers to investigate components such as cholinesterase activity (the enzymes that deactivate ach), and their relationship with POD [28]. The studies reviewed showed lower plasma activity of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), preoperatively, in the patients that developed POD than in patients without POD [28,64]. Additional to the cholinergic anti-inflammatory pathway, some researchers have also investigated a relationship between CRP and POD, although their studies showed no correlation [65,66]. The differences in pre-op and post-op albumin (Δalb) was also studied as a potential predictor for POD, with results suggesting a statistically significant correlation [17,23]. In addition, hip and knee arthroplasty surgeries are associated with the embolism of materials such as air, cement, and fat. Considering this, some researchers investigated a possible correlation between the number of emboli and POD, with their studies showing no statistically significant results [3,67].
Another theory suggests that patients with microstructural abnormalities are more prone to develop POD under the stress of surgery, due to brain homeostasis disturbance. Cavallari M. et al. studied the association of brain microstructural anomalies, assessed by MRI before surgery using the diffusion tensor imaging (DTI) technique, with postoperative delirium incidence and severity after non-cardiac surgery. Their findings showed a significant association of presurgical DTI irregularities in a variety of brain regions, such as the thalamus and hippocampus, with postoperative delirium incidence and severity. The regions involved may explain the neuropsychological manifestations that take place in POD [68].
Summarizing, although the pathophysiology of POD is not fully elucidated yet, research has been conducted to examine potential biomarkers that predict POD, focusing on the putative pathophysiological pathways. So far, there seems to be a correlation between the pre-op Ache/BuChE activity and POD. Furthermore, low CSF, Ab42, Ab42/tau, and Ab40/tau seem to predict POD, although more studies are required to clarify the relationship between these factors and POD to make their use in clinical practice possible. Lastly, some studies showed a significant correlation between Δalb and POD.

3.1.6. Treatment

There is broad evidence that with the identification of patients at risk of developing POD and the initiation of a multiple component prevention program (Scheme 2), delirium is preventable in most cases [32,34,48]. Studies that implemented such protocols showed up to 99.33% POD reduction [48].
Protocols for risk stratification might include numerous risk factors, such as age, substance abuse, preoperative cognitive impairment (MMSE scores or other screening tools), sensory impairment, dependence in ≥1 ADL (activities of daily life), history of POD, history of falls, and chronic benzodiazepine usage [32,34,48]. A good example of a risk stratification protocol is the one used by Kristen E Radcliff et al., which is a score test including age, history of forgetfulness/hallucinations/falls/postoperative confusion, inability to perform higher brain functions; and performance on a simple mental exam. According to their score, patients are classified as low/medium/high risk [34]. After identifying the high-risk patients, a multiple component POD prevention approach should be set in motion, which includes preoperative, intraoperative, PACU (post anesthesia care unit), and postoperative evidence-based interventions.
Firstly, a fast-track approach should be used as it reduces the risk of POD [69].
Preoperative: Flag as high risk, gentle preoperative hydration (75 mL normal saline solution for 2–4 h) [32,34]. Avoid atropine, scopolamine, barbiturates, propranolol, and benzodiazepines [13,34].
Intraoperative: Avoid hypoxemia, hypercarbia/hypocarbia, and hypotension, and medications listed above [13,34]. Monitor vital signs, mode of anesthesia (regional or general) is not significant [11,16,21,40]. In addition, avoid intraoperative opioids [9,47,51].
PACU: Intravenous normal saline solution at 125 mL per hour. Consider proton pump inhibitor instead of H2 blockers. Avoid narcotics and benzodiazepines, and monitor vital signs [13,34].
Postoperative (general measures): Locate patient close to nursing station, continuous pulse oximetry per protocol and keep oxygen saturation at 95%, check vitals every 4 h, daily laboratory test results. daily calorie counts. Foley catheter out when the patient has good urine output. Avoid physical/chemical restraints; no H2 blocker, no sleeping pills [13,34].
For analgesia: Paracetamol up to 4 g per day, half lidocaine patch 5% for 12 h per day on each side of incision once surgical dressing is removed [34]. Opioid patient control analgesia (PCA) should be used if needed, since multiple studies showed no correlation with POD [18,49,52,70,71]. Furthermore, addition of parecoxib reduced the incidence of POD [24]. Some studies reported lower incidence of POD in patients that received nerve blocks in addition to PCA vs. patients that received PCA alone after the operation [36,72]. Some studies suggest that the use of olanzapine (10 mg) postoperative as a preventive measure for POD yields positive results and drastically reduces the incidence of POD [17,51].
In addition, according to the hospital elder life program (HELP) protocol: Orientation (reality/time), frequent communication with patient, involvement of family in daily care, one-to-one supervision to help with eating/toileting/turning, alternative methods to help with sleep, and quick mobilization of patient out of bed with physical therapy. These are measures that have to be applied in high risk individuals in order to prevent delirium [34].

3.2. POCD

POCD is defined as a syndrome of prolonged impairment of cognitive function, occurring weeks to months after surgery, and its diagnosis is possible by comparing the results of pre-op and post-op neurocognitive domain testing. Features of POCD include limitations in memory, intellectual ability, and executive function, and it is distinct from delirium and dementia [73]. The International Study of Postoperative Cognitive Dysfunction (ISPOCD) stated that patients had cognitive dysfunction when two Z-scores in individual cognitive tests, or the combined Z-scores, were 1.96 or more. This definition took into account general deterioration (in all tests) or substantial deterioration in only some tests, and it is applicable to all nationalities. The ISPOCD divides POCD as early (1 week post-op) and late (3 months post-op), whilst other studies also report a third category of one-year incidence of POCD [74,75,76,77,78]. It is important to clarify that early POCD is distinct from late POCD, and the presence of the one entity does not increase the risk of the other [65].

3.2.1. Epidemiology

The literature shows a wide range of incidence for early and late POCD. More specifically, early POCD (6.7%–75%) with a median of 19.3%, and late POCD (8%–45%) with a median of 10% [65,66,69,75,76,77,78,79,80,81,82,83,84,85,86,87]. Some studies report the one-year incidence of POCD with a range of (0%–13.7%) and a median of 2.8% [75,76,77,78] (Figure 1). The high variation between studies can be attributed to the great variety of tests that are used to assess neurocognitive function.

3.2.2. Risk Factors

Identifying risk factors for POCD after elective THA/TKA is of utmost importance, since the basis for treatment is the elimination of these factors, in addition to other interventions. Older age (>70 years, with a range of 65–82 years, as reported in various studies) and a high BMI seem to correlate with increased risk of POCD [84,85,86,88,89]. Studies that examined the relationship between sex and POCD show conflicting results, with Li Yan et al. stating that females are more prone to POCD, and Lene Krenk et al. stating that there is no relationship between sex and POCD [65,89]. Perhaps, the difference these in results is due to the fact that the studies examined different populations with different surgical protocols. For example, Li Yan et al. included patients >18 years old undergoing THA, while Lene Krenk et al. included patients >60 years old undergoing fast-track THA and TKA.
Preoperative cognitive impairment is associated with POCD, although we cannot be certain that this applies in both early and late POCD [65,76,89]. Since POCD is a condition defined by the impairment of neurocognitive domains, the need to investigate a possible relationship between cognitive reserve and POCD is obvious. The concept of cognitive reserve (CR) suggests that innate intelligence or aspects of life experience, such as educational or occupational attainments, may supply reserve in the form of a set of skills or repertoires that allows people to cope with cognitive impairment conditions better than others (i.e., progressive AD) [90]. Postler et al. found that a higher education level was associated with a lower incidence of POCD, and Si-Hai Zhu et al. stated that a lower education level was associated with a higher incidence of POCD. While these studies show a correlation between education level and POCD, J E Scott et al. stated that cognitive reserve in their study correlated with a specific test in a specific subset of patients; thus, they were not able to make a general statement on CR and POCD [86,88,91]. Summarizing, we can say that higher CR, and especially higher education level, acts as a protective factor to POCD.
Some studies examined the role of OSA and POCD, and showed no correlation [65]. Regarding mode of anesthesia (general vs. regional) or BIS (bispectral index) and POCD, no correlation was found [40,78,92,93,94,95,96]. In addition, active warming during surgery, cerebral oxygen desaturation, and uneven saturation during surgery, were shown to increase the incidence of POCD [85,87,97,98]. Si-Hai Zhu et al. showed that perioperative transfusion of >3 units of blood is associated with increased risk of POCD at 1 week; however, it is not clear if this is due to the underlining condition that mandated the need for transfusion or the proinflammatory effects from the transfusions themselves. The authors were unable to understand which scenario increased the risk because they did not measure the time course of the inflammatory mediators [88].

3.2.3. Diagnosis

POCD diagnosis comes with its definition. It is achieved by comparing the preoperative and postoperative scores of different neurocognitive tests. The most frequently used test was the mini-mental state exam (MMSE), followed by the Montreal cognitive assessment (MoCA). Furthermore, there were many different variations of domain-specific tests (i.e., tests for memory, executive function, etc.) These tests are performed by giving the patient several cognitive tasks, such as finding similarities, naming objects, recalling words, and more, in order to assess several cognitive abilities.
As with POD, researchers attempted to identify biomarkers to predict POCD. Alzheimer’s biomarkers (CSF AB 42, P-tau, P-tau) were investigated as possible predictive markers for POCD. Reviewing the literature, we found that lower CSF, Ab42, and T-tau/Ab42, and P-tau/Ab42 are correlated with POCD incidence [28,75], while T-tau and P-tau alone do not correlate with POCD [66,75]. However, still more studies are needed to make these results clinically applicable. In some studies, the relationship between CRP and POCD was investigated without any correlation [65,66]. In addition, many studies investigated the relationship between the intraoperative emboli and POCD, and again found no correlation [67,79,80,99].

3.2.4. Treatment

There is no specific treatment for POCD, and usually it resolves itself within a period of months. The solution for the clinician, to minimize POCD risk to their patient, is reversing the risk factors and applying some of the interventions described in the literature (Scheme 3 and Table 3).
General measures in order to ensure adequate brain oxygenation and keep the patient physiologically stable should be used. Vital sign monitoring, administration of adequate fluids to keep the patients hemodynamically stable, administration of oxygen, and frequent patient–nurse/doctor communication are such measures. In addition, a fast-track approach should be used [65,69], the mode of anesthesia not being significant [40,78,92,93,94,96]. For the pain, if needed, opioids can be used with caution and with appropriate doses, since they do not correlate with POCD [65,69]. PCA with fentanyl is preferred over morphine, since the latter was associated with lower MMSE scores [79]. Additionally, our literature review showed two more interventions that can be used. The first one is supported by a study conducted by Chia-Min Cheng et al., in which patients were submitted to a 20 min cognitive stimulation session daily for 6 days. This session included the recalling of past events, word games, and current event discussion. The intervention group showed lower POCD than the control group [100]. The second is the addition of parecoxib during the operation, which lowered early POCD, although it had no effect on late POCD [101].

4. Conclusions

POD after elective THA/TKA is a common complication that is related with increased morbidity. It has a median incidence of 14.8% and a high variation between different studies due to heterogeneous study protocols. Knowledge of the risk factors is mandatory since their implementation in risk stratification protocols is the basis of treatment. The diagnosis can be achieved with CAM, which is a tool that can be easily used in daily clinical practice. After risk stratification, multiple component prevention programs should be activated in high-risk patients. Regarding pain, the current literature review shows that opioid patient-controlled anesthesia does not correlate with POD, and, if needed, it should be used in order to relieve pain. In addition, adding parecoxib and/or nerve block to the PCA reduces the risk of POD. Future research should focus on clarifying the relationship between risk factors such as depression and alcohol dependence/abuse with POD, since they are both common diseases in the population. In addition, more research is needed in order to make the use of predicting biomarkers feasible in clinical practice.
POCD is a frequently occurring condition after elective THA/TKA, with an incidence of 19.3% for early and 10% for late POCD. Cognitive reserve and preoperative cognitive decline correlates with POCD. The diagnosis is made by comparing the scores of preoperative and postoperative neurocognitive tests. Previous research explored the relationship between Alzheimer’s markers preoperatively and POCD, with the results showing a correlation, although their use in clinical practice remains impracticable. More research is needed to make their use on a daily basis possible. While most patients recover in a period of months, specific interventions, in addition to general measures, are needed to reduce the risk of POCD. Future research should focus on quantifying the relationship between cognitive reserve and preoperative cognitive decline with POCD. Studies that examine the connection between preoperative cognitive test scores and POCD can lead to this quantification.

Author Contributions

Conceptualization, E.P. and A.K.; Investigation, P.K. and T.Z.; Project administration, I.G. (Ioannis Gkiatas); Supervision, E.P. and A.K.; Visualization, P.K., T.Z., I.G. (Ioannis Gkiatas), I.G. (Ioannis Gelalis) and I.K.-A.; Writing original draft, P.K. and T.Z.; Writing –review and editing, P.K., T.Z., I.G. (Ioannis Gkiatas), I.G. (Ioannis Gelalis), E.P., A.K. and I.K.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ferguson, R.J.; Palmer, A.J.; Taylor, A.; Porter, M.L.; Malchau, H.; Glyn-Jones, S. Hip replacement. Lancet 2018, 392, 1662–1671. [Google Scholar] [CrossRef]
  2. Maradit Kremers, H.; Larson, D.R.; Crowson, C.S.; Kremers, W.K.; Washington, R.E.; Steiner, C.A.; Jiranek, W.A.; Berry, D.J. Prevalence of Total Hip and Knee Replacement in the United States. J. Bone Jt. Surg.-Am. Vol. 2015, 97, 1386–1397. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Gai, N.; Lavi, R.; Jones, P.M.; Lee, H.; Naudie, D.; Bainbridge, D. The use of point-of-care ultrasound to diagnose patent foramen ovale in elective hip and knee arthroplasty patients and its association with postoperative delirium. Can. J. Anaesth. 2018, 65, 619–626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Viramontes, O.; Luan Erfe, B.M.; Erfe, J.M.; Brovman, E.Y.; Boehme, J.; Bader, A.M.; Urman, R.D. Cognitive impairment and postoperative outcomes in patients undergoing primary total hip arthroplasty: A systematic review. J. Clin. Anesth. 2019, 56, 65–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Räsänen, P.; Paavolainen, P.; Sintonen, H.; Koivisto, A.-M.; Blom, M.; Ryynänen, O.-P.; Roine, R.P. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop. 2007, 78, 108–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Robertsson, O.; Bizjajeva, S.; Fenstad, A.M.; Furnes, O.; Lidgren, L.; Mehnert, F.; Odgaard, A.; Pedersen, A.B.; Havelin, L.I. Knee arthroplasty in Denmark, Norway and Sweden: A pilot study from the Nordic Arthroplasty Register Association. Acta Orthop. 2010, 81, 82–89. [Google Scholar] [CrossRef]
  7. Aziz, K.T.; Best, M.J.; Naseer, Z.; Skolasky, R.L.; Ponnusamy, K.E.; Sterling, R.S.; Khanuja, H.S. The Association of Delirium with Perioperative Complications in Primary Elective Total Hip Arthroplasty. Clin. Orthop. Surg. 2018, 10, 286–291. [Google Scholar] [CrossRef]
  8. Petersen, P.B.; Jørgensen, C.C.; Kehlet, H. Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group Delirium after fast-track hip and knee arthroplasty—A cohort study of 6331 elderly patients. Acta Anaesthesiol. Scand. 2017, 61, 767–772. [Google Scholar] [CrossRef]
  9. Weinstein, S.M.; Poultsides, L.; Baaklini, L.R.; Mörwald, E.E.; Cozowicz, C.; Saleh, J.N.; Arrington, M.B.; Poeran, J.; Zubizarreta, N.; Memtsoudis, S.G. Postoperative delirium in total knee and hip arthroplasty patients: A study of perioperative modifiable risk factors. Br. J. Anaesth. 2018, 120, 999–1008. [Google Scholar] [CrossRef] [Green Version]
  10. Wang, L.; Seok, S.; Kim, S.; Kim, K.; Lee, S.; Lee, K. The Risk Factors of Postoperative Delirium after Total Knee Arthroplasty. J. Knee Surg. 2017, 30, 600–605. [Google Scholar] [CrossRef]
  11. Jankowski, C.J.; Trenerry, M.R.; Cook, D.J.; Buenvenida, S.L.; Stevens, S.R.; Schroeder, D.R.; Warner, D.O. Cognitive and functional predictors and sequelae of postoperative delirium in elderly patients undergoing elective joInt. arthroplasty. Anesth. Analg. 2011, 112, 1186–1193. [Google Scholar] [CrossRef] [PubMed]
  12. Huang, J.; Bin Abd Razak, H.R.; Yeo, S.J. Incidence of postoperative delirium in patients undergoing total knee arthroplasty-an Asian perspective. Ann. Transl. Med. 2017, 5, 321. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Rogers, M.P.; Liang, M.H.; Daltroy, L.H.; Eaton, H.; Peteet, J.; Wright, E.; Albert, M. Delirium after elective orthopedic surgery: Risk factors and natural history. Int. J. Psychiatry Med. 1989, 19, 109–121. [Google Scholar] [CrossRef] [PubMed]
  14. Slim, K.; Nini, E.; Forestier, D.; Kwiatkowski, F.; Panis, Y.; Chipponi, J. Methodological index for non-randomized studies (MINORS): Development and validation of a new instrument: Methodological index for non-randomized studies. ANZ J. Surg. 2003, 73, 712–716. [Google Scholar] [CrossRef] [PubMed]
  15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 2nd ed.; American Psychiatric Association: Washington, DC, USA, 2013; ISBN 978-0-89042-554-1. [Google Scholar]
  16. Flink, B.J.; Rivelli, S.K.; Cox, E.A.; White, W.D.; Falcone, G.; Vail, T.P.; Young, C.C.; Bolognesi, M.P.; Krystal, A.D.; Trzepacz, P.T.; et al. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. Anesthesiology 2012, 116, 788–796. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Larsen, K.A.; Kelly, S.E.; Stern, T.A.; Bode, R.H.; Price, L.L.; Hunter, D.J.; Gulczynski, D.; Bierbaum, B.E.; Sweeney, G.A.; Hoikala, K.A.; et al. Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: A randomized, controlled trial. Psychosomatics 2010, 51, 409–418. [Google Scholar] [CrossRef]
  18. Chung, K.S.; Lee, J.K.; Park, J.S.; Choi, C.H. Risk factors of delirium in patients undergoing total knee arthroplasty. Arch. Gerontol. Geriatr. 2015, 60, 443–447. [Google Scholar] [CrossRef] [PubMed]
  19. Lowery, D.P.; Wesnes, K.; Ballard, C.G. Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium. Dement. Geriatr. Cogn. Disord. 2007, 23, 390–394. [Google Scholar] [CrossRef]
  20. Kudoh, A.; Takase, H.; Matsuno, S.; Katagai, H. A history of aggression is a risk factor for postoperative confusion in elderly male drinkers. J. Anesth. 2007, 21, 13–18. [Google Scholar] [CrossRef]
  21. Scott, J.E.; Mathias, J.L.; Kneebone, A.C. Incidence of delirium following total joInt. replacement in older adults: A meta-analysis. Gen. Hosp. Psychiatry 2015, 37, 223–229. [Google Scholar] [CrossRef]
  22. Sampson, E.L.; Raven, P.R.; Ndhlovu, P.N.; Vallance, A.; Garlick, N.; Watts, J.; Blanchard, M.R.; Bruce, A.; Blizard, R.; Ritchie, C.W. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int. J. Geriatr. Psychiatry 2007, 22, 343–349. [Google Scholar] [CrossRef] [PubMed]
  23. Qi, J.; Liu, C.; Chen, L.; Chen, J. Postoperative Serum Albumin Decrease Independently Predicts Delirium in the Elderly Subjects after Total JoInt. Arthroplasty. Curr. Pharm. Des. 2020, 26, 386–394. [Google Scholar] [CrossRef] [PubMed]
  24. Mu, D.-L.; Zhang, D.-Z.; Wang, D.-X.; Wang, G.; Li, C.-J.; Meng, Z.-T.; Li, Y.-W.; Liu, C.; Li, X.-Y. Parecoxib Supplementation to Morphine Analgesia Decreases Incidence of Delirium in Elderly Patients After Hip or Knee Replacement Surgery: A Randomized Controlled Trial. Anesth. Analg. 2017, 124, 1992–2000. [Google Scholar] [CrossRef] [PubMed]
  25. Cunningham, E.L.; Mawhinney, T.; Beverland, D.; O’Brien, S.; McAuley, D.F.; Cairns, R.; Passmore, P.; McGuinness, B. Observational cohort study examining apolipoprotein E status and preoperative neuropsychological performance as predictors of post-operative delirium in an older elective arthroplasty population. Age Ageing 2017, 46, 779–786. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Fan, Y.-X.; Liu, F.-F.; Jia, M.; Yang, J.-J.; Shen, J.-C.; Zhu, G.-M.; Zhu, S.-H.; Li, W.-Y.; Yang, J.-J.; Ji, M.-H. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: A preliminary study. Arch. Gerontol. Geriatr. 2014, 59, 181–185. [Google Scholar] [CrossRef]
  27. Cerejeira, J.; Batista, P.; Nogueira, V.; Vaz-Serra, A.; Mukaetova-Ladinska, E.B. The stress response to surgery and postoperative delirium: Evidence of hypothalamic-pituitary-adrenal axis hyperresponsiveness and decreased suppression of the GH/IGF-1 Axis. J. Geriatr. Psychiatry Neurol. 2013, 26, 185–194. [Google Scholar] [CrossRef]
  28. Cerejeira, J.; Nogueira, V.; Luís, P.; Vaz-Serra, A.; Mukaetova-Ladinska, E.B. The cholinergic system and inflammation: Common pathways in delirium pathophysiology. J. Am. Geriatr. Soc. 2012, 60, 669–675. [Google Scholar] [CrossRef]
  29. Krenk, L.; Rasmussen, L.S.; Hansen, T.B.; Bogø, S.; Søballe, K.; Kehlet, H. Delirium after fast-track hip and knee arthroplasty. Br. J. Anaesth. 2012, 108, 607–611. [Google Scholar] [CrossRef] [Green Version]
  30. Lowery, D.P.; Wesnes, K.; Brewster, N.; Ballard, C. Quantifying the association between computerised measures of attention and confusion assessment method defined delirium: A prospective study of older orthopaedic surgical patients, free of dementia. Int. J. Geriatr. Psychiatry 2008, 23, 1253–1260. [Google Scholar] [CrossRef]
  31. Priner, M.; Jourdain, M.; Bouche, G.; Merlet-Chicoine, I.; Chaumier, J.-A.; Paccalin, M. Usefulness of the short IQCODE for predicting postoperative delirium in elderly patients undergoing hip and knee replacement surgery. Gerontology 2008, 54, 116–119. [Google Scholar] [CrossRef]
  32. Freter, S.H.; Dunbar, M.J.; MacLeod, H.; Morrison, M.; MacKnight, C.; Rockwood, K. Predicting post-operative delirium in elective orthopaedic patients: The Delirium Elderly At-Risk (DEAR) instrument. Age Ageing 2005, 34, 169–171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Farlinger, C.; Clarke, H.; Wong, C.L. Perioperative pregabalin and delirium following total hip arthroplasty: A post hoc analysis of a double-blind randomized placebo-controlled trial. Can. J. Anaesth. 2018, 65, 1269–1270. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Radcliff, K.E.; Orozco, F.R.; Quinones, D.; Rhoades, D.; Sidhu, G.S.; Ong, A.C. Preoperative risk stratification reduces the incidence of perioperative complications after total knee arthroplasty. J. Arthroplast. 2012, 27, 77–80. [Google Scholar] [CrossRef] [PubMed]
  35. Pulido, L.; Parvizi, J.; Macgibeny, M.; Sharkey, P.F.; Purtill, J.J.; Rothman, R.H.; Hozack, W.J. In hospital complications after total joInt. arthroplasty. J. Arthroplast. 2008, 23, 139–145. [Google Scholar] [CrossRef]
  36. Kinjo, S.; Lim, E.; Sands, L.P.; Bozic, K.J.; Leung, J.M. Does using a femoral nerve block for total knee replacement decrease postoperative delirium? BMC Anesth. 2012, 12, 4. [Google Scholar] [CrossRef] [Green Version]
  37. Fisher, B.W.; Flowerdew, G. A simple model for predicting postoperative delirium in older patients undergoing elective orthopedic surgery. J. Am. Geriatr. Soc. 1995, 43, 175–178. [Google Scholar] [CrossRef]
  38. Williams-Russo, P.; Urquhart, B.L.; Sharrock, N.E.; Charlson, M.E. Post-operative delirium: Predictors and prognosis in elderly orthopedic patients. J. Am. Geriatr. Soc. 1992, 40, 759–767. [Google Scholar] [CrossRef]
  39. Kudoh, A.; Takase, H.; Takahira, Y.; Takazawa, T. Postoperative confusion increases in elderly long-term benzodiazepine users. Anesth. Analg. 2004, 99, 1674–1678. [Google Scholar] [CrossRef]
  40. Williams-Russo, P.; Sharrock, N.E.; Mattis, S.; Szatrowski, T.P.; Charlson, M.E. Cognitive effects after epidural vs. general anesthesia in older adults. A randomized trial. JAMA 1995, 274, 44–50. [Google Scholar] [CrossRef]
  41. Rade, M.C.; Yadeau, J.T.; Ford, C.; Reid, M.C. Postoperative delirium in elderly patients after elective hip or knee arthroplasty performed under regional anesthesia. HSS J. 2011, 7, 151–156. [Google Scholar] [CrossRef] [Green Version]
  42. Culley, D.J.; Flaherty, D.; Fahey, M.C.; Rudolph, J.L.; Javedan, H.; Huang, C.-C.; Wright, J.; Bader, A.M.; Hyman, B.T.; Blacker, D.; et al. Poor Performance on a Preoperative Cognitive Screening Test Predicts Postoperative Complications in Older Orthopedic Surgical Patients. Anesthesiology 2017, 127, 765–774. [Google Scholar] [CrossRef] [PubMed]
  43. Puustinen, J.; Luostarinen, L.; Luostarinen, M.; Pulliainen, V.; Huhtala, H.; Soini, M.; Suhonen, J. The Use of MoCA and Other Cognitive Tests in Evaluation of Cognitive Impairment in Elderly Patients Undergoing Arthroplasty. Geriatr. Orthop. Surg. Rehabil. 2016, 7, 183–187. [Google Scholar] [CrossRef]
  44. Xie, Z.; Swain, C.A.; Ward, S.A.P.; Zheng, H.; Dong, Y.; Sunder, N.; Burke, D.W.; Escobar, D.; Zhang, Y.; Marcantonio, E.R. Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium. Ann. Clin. Transl. Neurol. 2014, 1, 319–328. [Google Scholar] [CrossRef]
  45. Xie, H.; Huang, D.; Zhang, S.; Hu, X.; Guo, J.; Wang, Z.; Zhou, G. Relationships between adiponectin and matrix metalloproteinase-9 (MMP-9) serum levels and postoperative cognitive dysfunction in elderly patients after general anesthesia. Aging Clin. Exp. Res. 2016, 28, 1075–1079. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Dighe, K.; Clarke, H.; McCartney, C.J.; Wong, C.L. Perioperative gabapentin and delirium following total knee arthroplasty: A post-hoc analysis of a double-blind randomized placebo-controlled trial. Can. J. Anaesth. 2014, 61, 1136–1137. [Google Scholar] [CrossRef]
  47. Cunningham, E.L.; McGuinness, B.; McAuley, D.F.; Toombs, J.; Mawhinney, T.; O’Brien, S.; Beverland, D.; Schott, J.M.; Lunn, M.P.; Zetterberg, H.; et al. CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study. Ann. Surg. 2019, 269, 1200–1205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Duque, A.F.; Post, Z.D.; Orozco, F.R.; Lutz, R.W.; Ong, A.C. A Proactive Approach to High Risk Delirium Patients Undergoing Total JoInt. Arthroplasty. J. Arthroplast. 2018, 33, 1171–1176. [Google Scholar] [CrossRef]
  49. Petre, B.M.; Roxbury, C.R.; McCallum, J.R.; Defontes, K.W.; Belkoff, S.M.; Mears, S.C. Pain reporting, opiate dosing, and the adverse effects of opiates after hip or knee replacement in patients 60 years old or older. Geriatr. Orthop. Surg. Rehabil. 2012, 3, 3–7. [Google Scholar] [CrossRef] [Green Version]
  50. Bellelli, G.; Speciale, S.; Trabucchi, M. Predictors of delirium during in-hospital rehabilitation in elderly patients after hip arthroplasty. Age Ageing 2005, 34, 532. [Google Scholar] [CrossRef]
  51. Jain, F.A.; Brooks, J.O.; Larsen, K.A.; Kelly, S.E.; Bode, R.H.; Sweeney, G.A.; Stern, T.A. Individual risk profiles for postoperative delirium after joInt. replacement surgery. Psychosomatics 2011, 52, 410–416. [Google Scholar] [CrossRef]
  52. Nandi, S.; Harvey, W.F.; Saillant, J.; Kazakin, A.; Talmo, C.; Bono, J. Pharmacologic risk factors for post-operative delirium in total joInt. arthroplasty patients: A case-control study. J. Arthroplast. 2014, 29, 268–271. [Google Scholar] [CrossRef] [PubMed]
  53. Yen, T.E.; Allen, J.C.; Rivelli, S.K.; Patterson, S.C.; Metcalf, M.R.; Flink, B.J.; Mirrakhimov, A.E.; Lagoo, S.A.; Vail, T.P.; Young, C.C.; et al. Association between Serum IGF-I levels and Postoperative Delirium in Elderly Subjects Undergoing Elective Knee Arthroplasty. Sci. Rep. 2016, 6, 20736. [Google Scholar] [CrossRef] [PubMed]
  54. Gupta, R.M.; Parvizi, J.; Hanssen, A.D.; Gay, P.C. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: A case-control study. Mayo Clin. Proc. 2001, 76, 897–905. [Google Scholar] [CrossRef]
  55. Wang, J.; Li, Z.; Yu, Y.; Li, B.; Shao, G.; Wang, Q. Risk factors contributing to postoperative delirium in geriatric patients postorthopedic surgery: Postoperative delirium. Asia-Pac. Psychiatry 2015, 7, 375–382. [Google Scholar] [CrossRef] [PubMed]
  56. Simpson, C.J.; Kellett, J.M. The relationship between pre-operative anxiety and post-operative delirium. J. Psychosom. Res. 1987, 31, 491–497. [Google Scholar] [CrossRef]
  57. Gholson, J.J.; Bedard, N.A.; Dowdle, S.B.; Brown, T.S.; Gao, Y.; Callaghan, J.J. Total JoInt. Arthroplasty in Patients With Schizophrenia: How Much Does It Increase the Risk of Complications? J. Arthroplast. 2018, 33, 2082–2086. [Google Scholar] [CrossRef]
  58. Price, C.C.; Levy, S.-A.; Tanner, J.; Garvan, C.; Ward, J.; Akbar, F.; Bowers, D.; Rice, M.; Okun, M. Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson’s Disease: Considerations from a Pilot Study. J. Parkinsons Dis. 2015, 5, 893–905. [Google Scholar] [CrossRef] [Green Version]
  59. Newman, J.M.; Sodhi, N.; Dalton, S.E.; Khlopas, A.; Newman, R.P.; Higuera, C.A.; Mont, M.A. Does Parkinson Disease Increase the Risk of Perioperative Complications After Total Hip Arthroplasty? A Nationwide Database Study. J. Arthroplast. 2018, 33, S162–S166. [Google Scholar] [CrossRef]
  60. Van Meenen, L.C.C.; van Meenen, D.M.P.; de Rooij, S.E.; ter Riet, G. Risk prediction models for postoperative delirium: A systematic review and meta-analysis. J. Am. Geriatr. Soc. 2014, 62, 2383–2390. [Google Scholar] [CrossRef]
  61. Inouye, S.K.; van Dyck, C.H.; Alessi, C.A.; Balkin, S.; Siegal, A.P.; Horwitz, R.I. Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann. Intern. Med. 1990, 113, 941–948. [Google Scholar] [CrossRef]
  62. Steiner, L.A. Postoperative delirium. Part 1: Pathophysiology and risk factors. Eur. J. Anaesthesiol. 2011, 28, 628–636. [Google Scholar] [CrossRef] [PubMed]
  63. Wang, Y.; Shen, X. Postoperative delirium in the elderly: The potential neuropathogenesis. Aging Clin. Exp. Res. 2018, 30, 1287–1295. [Google Scholar] [CrossRef] [PubMed]
  64. Cerejeira, J.; Batista, P.; Nogueira, V.; Firmino, H.; Vaz-Serra, A.; Mukaetova-Ladinska, E.B. Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients. Age Ageing 2011, 40, 621–626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Krenk, L.; Kehlet, H.; Bæk Hansen, T.; Solgaard, S.; Soballe, K.; Rasmussen, L.S. Cognitive dysfunction after fast-track hip and knee replacement. Anesth. Analg. 2014, 118, 1034–1040. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Ji, M.-H.; Yuan, H.-M.; Zhang, G.-F.; Li, X.-M.; Dong, L.; Li, W.-Y.; Zhou, Z.-Q.; Yang, J.-J. Changes in plasma and cerebrospinal fluid biomarkers in aged patients with early postoperative cognitive dysfunction following total hip-replacement surgery. J. Anesth. 2013, 27, 236–242. [Google Scholar] [CrossRef]
  67. Patel, R.V.; Stygall, J.; Harrington, J.; Newman, S.P.; Haddad, F.S. Cerebral microembolization during primary total hip arthroplasty and neuropsychologic outcome: A pilot study. Clin. Orthop. Relat. Res. 2010, 468, 1621–1629. [Google Scholar] [CrossRef] [Green Version]
  68. Cavallari, M.; Dai, W.; Guttmann, C.R.G.; Meier, D.S.; Ngo, L.H.; Hshieh, T.T.; Callahan, A.E.; Fong, T.G.; Schmitt, E.; Dickerson, B.C.; et al. Neural substrates of vulnerability to postsurgical delirium as revealed by presurgical diffusion MRI. Brain 2016, 139, 1282–1294. [Google Scholar] [CrossRef] [Green Version]
  69. Krenk, L.; Rasmussen, L.S.; Kehlet, H. Delirium in the fast-track surgery setting. Best Pr. Res. Clin. Anaesthesiol. 2012, 26, 345–353. [Google Scholar] [CrossRef]
  70. Herrick, I.A.; Ganapathy, S.; Komar, W.; Kirkby, J.; Moote, C.A.; Dobkowski, W.; Eliasziw, M. Postoperative cognitive impairment in the elderly. Choice of patient-controlled analgesia opioid. Anaesthesia 1996, 51, 356–360. [Google Scholar] [CrossRef]
  71. Duggleby, W.; Lander, J. Cognitive status and postoperative pain: Older adults. J. Pain Symptom Manag. 1994, 9, 19–27. [Google Scholar] [CrossRef]
  72. Guay, J.; Johnson, R.L.; Kopp, S. Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults. Cochrane Database Syst. Rev. 2017, 10, CD011608. [Google Scholar] [CrossRef] [PubMed]
  73. O’Brien, H.; Mohan, H.; Hare, C.O.; Reynolds, J.V.; Kenny, R.A. Mind Over Matter? The Hidden Epidemic of Cognitive Dysfunction in the Older Surgical Patient. Ann. Surg. 2017, 265, 677–691. [Google Scholar] [CrossRef] [PubMed]
  74. Moller, J.T.; Cluitmans, P.; Rasmussen, L.S.; Houx, P.; Rasmussen, H.; Canet, J.; Rabbitt, P.; Jolles, J.; Larsen, K.; Hanning, C.D.; et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998, 351, 857–861. [Google Scholar] [CrossRef]
  75. Evered, L.; Silbert, B.; Scott, D.A.; Ames, D.; Maruff, P.; Blennow, K. Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction. Anesthesiology 2016, 124, 353–361. [Google Scholar] [CrossRef] [PubMed]
  76. Silbert, B.; Evered, L.; Scott, D.A.; McMahon, S.; Choong, P.; Ames, D.; Maruff, P.; Jamrozik, K. Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joInt. replacement surgery. Anesthesiology 2015, 122, 1224–1234. [Google Scholar] [CrossRef] [PubMed]
  77. Li, W.-X.; Luo, R.-Y.; Chen, C.; Li, X.; Ao, J.-S.; Liu, Y.; Yin, Y.-Q. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: A randomized controlled preliminary trial. Chin. Med. J. 2019, 132, 437–445. [Google Scholar] [CrossRef]
  78. Konishi, Y.; Evered, L.A.; Scott, D.A.; Silbert, B.S. Postoperative cognitive dysfunction after sevoflurane or propofol general anaesthesia in combination with spinal anaesthesia for hip arthroplasty. Anaesth. Intensive Care 2018, 46, 596–600. [Google Scholar] [CrossRef] [Green Version]
  79. Koch, S.; Forteza, A.; Lavernia, C.; Romano, J.G.; Campo-Bustillo, I.; Campo, N.; Gold, S. Cerebral fat microembolism and cognitive decline after hip and knee replacement. Stroke 2007, 38, 1079–1081. [Google Scholar] [CrossRef]
  80. Rodriguez, R.A.; Tellier, A.; Grabowski, J.; Fazekas, A.; Turek, M.; Miller, D.; Wherrett, C.; Villeneuve, P.J.; Giachino, A. Cognitive dysfunction after total knee arthroplasty: Effects of intraoperative cerebral embolization and postoperative complications. J. Arthroplast. 2005, 20, 763–771. [Google Scholar] [CrossRef]
  81. Rasmussen, L.S.; Schmehl, W.; Jakobsson, J. Comparison of xenon with propofol for supplementary general anaesthesia for knee replacement: A randomized study. Br. J. Anaesth. 2006, 97, 154–159. [Google Scholar] [CrossRef] [Green Version]
  82. Deo, H.; West, G.; Butcher, C.; Lewis, P. The prevalence of cognitive dysfunction after conventional and computer-assisted total knee replacement. Knee 2011, 18, 117–120. [Google Scholar] [CrossRef] [PubMed]
  83. Evered, L.; Scott, D.A.; Silbert, B.; Maruff, P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth. Analg. 2011, 112, 1179–1185. [Google Scholar] [CrossRef] [PubMed]
  84. Lin, R.; Zhang, F.; Xue, Q.; Yu, B. Accuracy of regional cerebral oxygen saturation in predicting postoperative cognitive dysfunction after total hip arthroplasty: Regional cerebral oxygen saturation predicts POCD. J. Arthroplast. 2013, 28, 494–497. [Google Scholar] [CrossRef] [PubMed]
  85. Ni, C.; Xu, T.; Li, N.; Tian, Y.; Han, Y.; Xue, Q.; Li, M.; Guo, X. Cerebral oxygen saturation after multiple perioperative influential factors predicts the occurrence of postoperative cognitive dysfunction. BMC Anesth. 2015, 15, 156. [Google Scholar] [CrossRef] [Green Version]
  86. Postler, A.; Neidel, J.; Günther, K.-P.; Kirschner, S. Incidence of early postoperative cognitive dysfunction and other adverse events in elderly patients undergoing elective total hip replacement (THR). Arch. Gerontol. Geriatr. 2011, 53, 328–333. [Google Scholar] [CrossRef]
  87. Salazar, F.; Doñate, M.; Boget, T.; Bogdanovich, A.; Basora, M.; Torres, F.; Fàbregas, N. Intraoperative warming and post-operative cognitive dysfunction after total knee replacement. Acta Anaesthesiol. Scand. 2011, 55, 216–222. [Google Scholar] [CrossRef]
  88. Zhu, S.-H.; Ji, M.-H.; Gao, D.-P.; Li, W.-Y.; Yang, J.-J. Association between perioperative blood transfusion and early postoperative cognitive dysfunction in aged patients following total hip replacement surgery. UPS J. Med. Sci. 2014, 119, 262–267. [Google Scholar] [CrossRef]
  89. Yan, L.; Liu, Q.; Zhu, Y.; Zhou, M.; Wang, H.; Qin, X.; Wang, L. Association of Preexisting Neurocognitive Impairments and Perioperative Neurocognitive Disorders for Hip JoInt. Replacement Surgery: A Prospective Cohort Study. Med. Sci. Monit. 2019, 25, 4617–4626. [Google Scholar] [CrossRef]
  90. Scarmeas, N.; Stern, Y. Cognitive Reserve and Lifestyle. J. Clin. Exp. Neuropsychol. 2003, 25, 625–633. [Google Scholar] [CrossRef]
  91. Scott, J.E.; Mathias, J.L.; Kneebone, A.C.; Krishnan, J. Postoperative cognitive dysfunction and its relationship to cognitive reserve in elderly total joInt. replacement patients. J. Clin. Exp. Neuropsychol. 2017, 39, 459–472. [Google Scholar] [CrossRef]
  92. Hou, R.; Wang, H.; Chen, L.; Qiu, Y.; Li, S. POCD in patients receiving total knee replacement under deep vs. light anesthesia: A randomized controlled trial. Brain Behav. 2018, 8, e00910. [Google Scholar] [CrossRef]
  93. Jones, M.J.; Piggott, S.E.; Vaughan, R.S.; Bayer, A.J.; Newcombe, R.G.; Twining, T.C.; Pathy, J.; Rosen, M. Cognitive and functional competence after anaesthesia in patients aged over 60: Controlled trial of general and regional anaesthesia for elective hip or knee replacement. BMJ 1990, 300, 1683–1687. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Macfarlane, A.J.R.; Prasad, G.A.; Chan, V.W.S.; Brull, R. Does regional anesthesia improve outcome after total knee arthroplasty? Clin. Orthop. Relat. Res. 2009, 467, 2379–2402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Hughes, D.; Bowes, J.B.; Brown, M.W. Changes in memory following general or spinal anaesthesia for hip arthroplasty. Anaesthesia 1988, 43, 114–117. [Google Scholar] [CrossRef] [PubMed]
  96. Nielson, W.R.; Gelb, A.W.; Casey, J.E.; Penny, F.J.; Merchant, R.N.; Manninen, P.H. Long-term cognitive and social sequelae of general versus regional anesthesia during arthroplasty in the elderly. Anesthesiology 1990, 73, 1103–1109. [Google Scholar] [CrossRef]
  97. Hizel, L.P.; Warner, E.D.; Wiggins, M.E.; Tanner, J.J.; Parvataneni, H.; Davis, R.; Penney, D.L.; Libon, D.J.; Tighe, P.; Garvan, C.W.; et al. Clock Drawing Performance Slows for Older Adults After Total Knee Replacement Surgery. Anesth. Analg. 2019, 129, 212–219. [Google Scholar] [CrossRef] [PubMed]
  98. Salazar, F.; Doñate, M.; Boget, T.; Bogdanovich, A.; Basora, M.; Torres, F.; Gracia, I.; Fàbregas, N. Relationship between intraoperative regional cerebral oxygen saturation trends and cognitive decline after total knee replacement: A post-hoc analysis. BMC Anesth. 2014, 14, 58. [Google Scholar] [CrossRef] [Green Version]
  99. Gray, A.C.; Torrens, L.; Howie, C.; Christie, J.; Robinson, C.M. Cognitive function and cerebral emboli after primary hip arthroplasty. HIP Int. 2008, 18, 40–45. [Google Scholar] [CrossRef]
  100. Cheng, C.-M.; Chiu, M.-J.; Wang, J.-H.; Liu, H.-C.; Shyu, Y.-I.L.; Huang, G.-H.; Chen, C.C.-H. Cognitive stimulation during hospitalization improves global cognition of older Taiwanese undergoing elective total knee and hip replacement surgery. J. Adv. Nurs. 2012, 68, 1322–1329. [Google Scholar] [CrossRef]
  101. Zhu, Y.-Z.; Yao, R.; Zhang, Z.; Xu, H.; Wang, L.-W. Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study. Medicine 2016, 95, e4082. [Google Scholar] [CrossRef]
Life 12 00314 sch001 550
Scheme 1. Qualitative evaluation of studies with MINORS scores and criteria used when contradicting evidence were present.
Scheme 1. Qualitative evaluation of studies with MINORS scores and criteria used when contradicting evidence were present.
Life 12 00314 sch001
Life 12 00314 sch002 550
Scheme 2. How to approach patient; risk stratification and multiple component prevention protocol for POD.
Scheme 2. How to approach patient; risk stratification and multiple component prevention protocol for POD.
Life 12 00314 sch002
Life 12 00314 g001 550
Figure 1. Incidence of early/late/1-year POCD and number of studies reporting it, respectively.
Figure 1. Incidence of early/late/1-year POCD and number of studies reporting it, respectively.
Life 12 00314 g001
Life 12 00314 sch003 550
Scheme 3. Bundled interventions for POCD risk reduction.
Scheme 3. Bundled interventions for POCD risk reduction.
Life 12 00314 sch003
Table
Table 1. Incidence rate and No. of studies for POD.
Table 1. Incidence rate and No. of studies for POD.
Incidence Rate of PODNo. of Studies
0–5%7
5–10%3
10–15%11
15–20%2
20–25%5
25–30%3
>30%4
Table
Table 2. Summarized results for POD.
Table 2. Summarized results for POD.
Risk factorsDiagnosis of PODTreatment
  • Older age (>70)
  • Pre-op comorbidities
  • Pre-op cognitive impairment
  • Dementia
  • Schizophrenia
  • Substance abuse
  • Chronic benzodiazepines usage
  • OSA
  • PD
CAM4 Life 12 00314 i001 criteria:
(1).
Acute onset and fluctuating course
(2).
Inattention
(3).
Disorganized thinking
(4).
Altered level of consciousness Diagnosis require the first 2 criteria and one of the remaining two
Risk stratification and implementation of a multiple component prevention protocol for high risk patients
Table
Table 3. POCD results summarized.
Table 3. POCD results summarized.
Risk FactorsDiagnosisTreatment
  • Older age
  • High BMI
  • Preoperative cognitive impairment
  • Perioperative transfusion of >3 units of blood
  • Cerebral oxygen desaturation or uneven saturation during surgery
Comparing the preoperative and postoperative scores of different neurocognitive testsMinimize the risk of POCD development by reversing risk factors and applying interventions
  • Fast-track approach should be used
  • Add parecoxib during the operation
  • Vital sign monitoring
  • Administration of adequate fluids
  • Administration of oxygen
  • Frequent patient–nurse/doctor communication
  • PCA with fentanyl is preferred over morphine
  • Paracetamol up to 4 g per day, use opioids with caution if needed
  • 20 min cognitive stimulation session daily for 6 days
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kitsis, P.; Zisimou, T.; Gkiatas, I.; Kostas-Agnantis, I.; Gelalis, I.; Korompilias, A.; Pakos, E. Postoperative Delirium and Postoperative Cognitive Dysfunction in Patients with Elective Hip or Knee Arthroplasty: A Narrative Review of the Literature. Life 2022, 12, 314. https://doi.org/10.3390/life12020314

AMA Style

Kitsis P, Zisimou T, Gkiatas I, Kostas-Agnantis I, Gelalis I, Korompilias A, Pakos E. Postoperative Delirium and Postoperative Cognitive Dysfunction in Patients with Elective Hip or Knee Arthroplasty: A Narrative Review of the Literature. Life. 2022; 12(2):314. https://doi.org/10.3390/life12020314

Chicago/Turabian Style

Kitsis, Petros, Theopisti Zisimou, Ioannis Gkiatas, Ioannis Kostas-Agnantis, Ioannis Gelalis, Anastasios Korompilias, and Emilios Pakos. 2022. "Postoperative Delirium and Postoperative Cognitive Dysfunction in Patients with Elective Hip or Knee Arthroplasty: A Narrative Review of the Literature" Life 12, no. 2: 314. https://doi.org/10.3390/life12020314

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop